[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355829-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355829-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","afp-stimulates-glucose-metabolic-reprogramming-contributing-to-hepatocellular-carcinoma-resist-sorafenib-through-activating-pi3kakt-signalling-pathway","AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway","","Alpha fetoprotein (AFP) regulates glucose metabolism reprogramming (GMR) linked to hepatocellular carcinoma (HCC) drug resistance, but its role in sorafenib response is unclear. Clinical liver cancer samples and multi-omics data were analyzed for AFP, GMR-related proteins, PKM2, and PI3K/AKT signalling proteins by IHC and Western blot. Cell assays (MTT, cloning, flow cytometry, TUNEL), metabolic measurements, and mechanistic studies using co-immunoprecipitation and immunofluorescence assessed AFP–PKM2 interactions. In vivo models tested tumour growth and tumorigenesis, showing AFP suppresses sorafenib-induced apoptosis via PI3K/AKT activation and PKM2-driven GMR, and AFP inhibition reduces tumours, reversible by PKM2 overexpression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/afp-stimulates-glucose-metabolic-reprogramming-contributing-to-hepatocellular-carcinoma-resist-sorafenib-through-activating-pi3kakt-signalling-pathway/355829/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/afp-stimulates-glucose-metabolic-reprogramming-contributing-to-hepatocellular-carcinoma-resist-sorafenib-through-activating-pi3kakt-signalling-pathway/355829.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study investigating regarding AFP and HCC?","Question",{"text":63,"@type":64},"The study investigates how AFP regulates glucose metabolic reprogramming (GMR) to influence HCC cell tolerance to sorafenib. It also examines the underlying signalling mechanisms involved.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers assess sorafenib resistance and related biological effects?",{"text":68,"@type":64},"They used assays such as MTT, cloning, flow cytometry, and TUNEL to evaluate HCC responses to sorafenib. They also measured glucose consumption, lactate dehydrogenase activity, and ATP production.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links AFP to GMR and sorafenib resistance?",{"text":72,"@type":64},"The results indicate AFP activates the PI3K/AKT signalling pathway and promotes GMR-associated protein expression and enzyme activity. AFP interaction with PKM2 stimulates PKM2 activity, enhancing GMR and contributing to sorafenib resistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355829,1790330777,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Journal of Cellular and Molecular Medicine  \nORIGINAL ARTICLE  OPEN ACCESS   \nAFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway  \nYuli Zhou1  | Siren Feng1  | Yi Chen1  | Bo Lin1  | Wei Li1  | Xu Dong1  | Kun Liu1  | Qiushi Yin1  | Mengsen Li1,2  | Mingyue Zhu1   \n1Key Laboratory of Tropical Translational Medicine, Ministry of Education, and Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, School of Basic Medical Sciences, Hainan Medical University, Haikou, Hainan Province, P.R. China | 2Department of Medical Oncology, Second Affiliated Hospital, Hainan Medical University, Haikou, Hainan Province, P.R. China  \nCorrespondence: Mengsen Li ([hy0206003@muhn.edu.cn](hy0206003@muhn.edu.cn)) | Mingyue Zhu ([hy0206120@muhn.edu.cn](hy0206120@muhn.edu.cn))  \nReceived: 5 July 2025 | Revised: 7 May 2026 | Accepted: 25 May 2026  \nKeywords: alpha fetoprotein | drug resistance | glucose metabolic reprogramming | hepatocellular carcinoma | PI3K/AKT signalling pathway  \nABSTRACT  \nAlpha fetoprotein (AFP) regulates glucose metabolism reprogramming (GMR) related to drug resistance of hepatocellular carcinoma (HCC) and remains unclear. This study explores the effect of AFP regulating GMR (Glucose metabolic reprogramming) on the tolerance of HCC cells to sorafenib. Thirty clinical liver cancer samples and multi-omics databases were collected; the expression of AFP, GMR-related proteins, pyruvate kinase M2 (PKM2), and the PI3K/AKT signalling pathway-associated proteins were assessed using immunohistochemistry (IHC) or Western blotting. MTT, cloning assays, flow cytometry, and TUNEL were performed to evaluate the effects of AFP on HCC resistance to sorafenib. Alterations in glucose consumption, lactate dehydrogenase activity, and ATP production were measured. Co-immunoprecipitation and immunofluorescence experiments were conducted to determine how AFP interacts with PKM2 . An in vivo mouse tumour model was used to investigate the restoration of tumorigenesis and development. The results indicated that AFP inhibited sorafenib-induced apoptosis of HCC cells. AFP activated the PI3K/AKT signalling pathway to promote the GMR-related protein expression and enzyme activity. Particularly, AFP's interaction with PKM2 stimulated the activity of PKM2 to enhance GMR, contributing to HCC resistance to sorafenib. In vivo experiments demonstrated that inhibition of AFP expression attenuated tumorigenesis and growth, and this effect was restored by overexpression of PKM2; PKM2 played a critical activated role in AFP mediating the GMR in HCC. In conclusion, AFP activates the PI3K/AKT signalling pathway to augment aerobic glycolysis in HCC cells, leading to HCC resistance to sorafenib. Inhibition of AFP expression and targeting of PKM2 may represent a novel approach for clinically reversing sorafenib tolerance in HCC patients.  \n1 | Introduction  \nHepatocellular carcinoma (HCC) constitutes the substantial majority (75%–85%) of primary liver malignancies and is a significant global problem. HCC is frequently diagnosed at an advanced stage, characterized by a high rate of metastasis, and is  \nassociated with a high mortality rate [1, 2] . Treatment options for patients with advanced HCC encompass various modalities such as local ablation, radiotherapy, chemotherapy, and molecular targeted therapy [3] . Sorafenib, a multi-targeted tyrosine kinase inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced HCC in  \n\n| Yuli Zhou, Siren Feng and Yi Chen contributed equally to this work and are co-first authors. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation f","cbCaidUfhexEeUPe","https://ap.wps.com/l/cbCaidUfhexEeUPe","pdf",5721049,17,"English","# Introduction\n## Hepatocellular carcinoma and sorafenib resistance\n## Role of AFP in cancer progression and resistance\n# Abstract / Study aims and key methods\n## Clinical samples and multi-omics analysis\n## Experimental models: in vitro assays and in vivo tumour model\n## Mechanistic focus: AFP–PKM2 interaction and PI3K/AKT pathway","[{\"question\":\"What is the study investigating regarding AFP and HCC?\",\"answer\":\"The study investigates how AFP regulates glucose metabolic reprogramming (GMR) to influence HCC cell tolerance to sorafenib. It also examines the underlying signalling mechanisms involved.\"},{\"question\":\"How did the researchers assess sorafenib resistance and related biological effects?\",\"answer\":\"They used assays such as MTT, cloning, flow cytometry, and TUNEL to evaluate HCC responses to sorafenib. They also measured glucose consumption, lactate dehydrogenase activity, and ATP production.\"},{\"question\":\"What mechanism links AFP to GMR and sorafenib resistance?\",\"answer\":\"The results indicate AFP activates the PI3K/AKT signalling pathway and promotes GMR-associated protein expression and enzyme activity. AFP interaction with PKM2 stimulates PKM2 activity, enhancing GMR and contributing to sorafenib resistance.\"}]","AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway | PDF",1790121236,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb2ef369bf45b2aeac2819d74db92f8e.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e33b11e099ffe9c246d324c9c57eca64.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63b64ad3ff7aa4a470b7397e6a5a500b.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fbfa89a3cee0af6f809ef3c96421d59.webp",980,1287]